Millipede has secured $90m from Boston Scientific, which also gained the right to acquire the mitral regurgitation treatment device maker.

Echo Health Ventures, a partnership between Cambia Health Solutions and Mosaic Health Solutions, co-led the health analytics platform's series B round.

New York Life's corporate venturing arm has provided $200m of capital for startups since it was established in 2012.

The nutritio tracking platform developer has raised series B1 capital from investors including Blue Cross Blue Shield of Massachusetts unit Zaffre Investments.

The strong R&D infrastructure, favourable government policies and abundance of growth opportunities make Singapore an ideal destination for exploring digital health growth in the South Asian region.

The spinout-focused fund could invest up to $9.2m in companies, with a focus on automated driving, artificial intelligence and healthcare.

Gilead Sciences, Ping An Ventures, Be The Match BioTherapies and existing investor Lilly Ventures Asia all backed the immunotherapy developer's series A round.